Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and Joan's Legacy
Lynne Regan, PhD
Yale University
New Haven
CT
Cancer-causing proteins called heat shock proteins (HSPs) protect cancer cells from the effects of chemotherapy. Dr. Regan is testing how inhibiting the protein chaperon HSP90 affects the growth of different lung cancer cells.